Round 1 Winners!
Proof of Usefulness Report

Adira Health

Analysis completed on 3/19/2026

+37
Proof of Usefulness Score
You're In Business

Adira Health targets a critical healthcare gap with digital treatments for eating disorders, showing good real-world utility and market relevance. However, the submission relies on severely exaggerated, unverifiable claims regarding traction ('most people have used my product') and financial metrics ('all time marketcap: 2500000'). Given its actual status as a piloted MVP chatbot, the final score reflects minimal verifiable traction and poor response quality.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+15.0
Audience Reach Impact+1.0
Technical Innovation+7.5
Evidence Of Traction+1.25
Market Timing Relevance+7.0
Functional Completeness+0.5
Subtotal+32.25
Usefulness Multiplierx1.15
Final Score+37

Project Details

Project URL
Description
Adira is a Digital Platform for use in the Treatment of Eating Disorders. By digitizing evidence based treatment methodologies Adira addresses the challenges of scale and accessibility, offering high quality interventions to people suffering from eating disorders, regardless of diagnosis or severity. Using Machine-Learning based tools we monitor, analyze and optimize treatment offering a personalized user experience. This allows for ever improving results, as we create the largest interactive ED treatment database. We’re launching our clinically validated system in 2023. Additionally we plan to seek a Class II medical device clearance from the FDA. The MVP we are currently piloting in the USA is a chatbot technology that covers various scenarios commonly encountered by people with eating disorders. Adira offers effective treatment options to help users improve nutrition, body image and cope with the urges, thoughts and beliefs that are barriers to recovery. Using familiar Interfaces, we provide clinically validated digital tools to augment human treatment for medium and severe cases, and that may be the primary tool for milder cases.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline